These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9838660)

  • 1. Cadaveric renal transplantations with prolonged warm ischemic times greater than 30 minutes.
    Hatsuse K; Kinukawa T; Hattori R; Fujita T; Ono Y; Ohshima S
    Transplant Proc; 1998 Nov; 30(7):3787-9. PubMed ID: 9838660
    [No Abstract]   [Full Text] [Related]  

  • 2. FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
    Hattori R; Ohshima S; Ono Y; Fujita T; Kinukawa T; Matsuura O
    Transplant Proc; 1998 Nov; 30(7):3801-3. PubMed ID: 9838666
    [No Abstract]   [Full Text] [Related]  

  • 3. Early cyclosporine concentration as predictor of graft survival in cadaveric renal transplantation.
    Salmela K; Kyllönen L
    Transplant Proc; 2001 Jun; 33(4):2441-3. PubMed ID: 11406202
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed graft function after renal transplantation from a non-heart-beating donors.
    Takai K; Kishi Y; Fujikawa K; Uchiyama K; Tsuchida M; Naito K
    Transplant Proc; 2003 Feb; 35(1):89-91. PubMed ID: 12591320
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W; Chen Y; Xing J; Tian P
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploration of the system for cadaver kidney transplantation with the non-heart-beating donor: efficacy of in situ cooling and low-dose cyclosporine.
    Kinukawa T; Ohshima S; Fujita T; Ono Y
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1524-6. PubMed ID: 8442174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation from asystolic cadaveric donors.
    Swanson M; Schweizer RT; Roper L; Bartus S; Hull D
    Transplant Proc; 1997 Dec; 29(8):3488. PubMed ID: 9414805
    [No Abstract]   [Full Text] [Related]  

  • 8. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center.
    Ushigome H; Okamoto M; Kadotani Y; Nakamura K; Akioka K; Ohmori Y; Yoshimura N
    Transplant Proc; 2002 Aug; 34(5):1681-2. PubMed ID: 12176533
    [No Abstract]   [Full Text] [Related]  

  • 10. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract]   [Full Text] [Related]  

  • 11. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged delayed graft function decreases graft survival in transplant patients taking cyclosporine.
    Fernández-Juarez G; Marcén R; Pascual J; Teruel JL; Rivera ME; Villafruela JJ; Mampaso F; Burgos FJ; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):338-9. PubMed ID: 11959314
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1999 Nov; 31(7A):31S-33S. PubMed ID: 10576040
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of using marginal cadaver donors and long cold ischemia time in renal transplant survival.
    Michelon T; Piovesan F; Santos P; Santos A; Keitel E; Bittar A; Neumann J; Garcia V
    Transplant Proc; 2000 Dec; 32(8):2586-8. PubMed ID: 11134717
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed graft function adversely affects one-year graft survival of cadaveric renal transplants.
    Carmellini M; Stefano RD; Filipponi F; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1996 Feb; 28(1):359-60. PubMed ID: 8644262
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
    Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
    Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidneys from border-age donors in the cyclosporine era: long-term function and outcome.
    Berardinelli L; Pasciucco A; Pozzoli E; Ferraresso M; Carini M; Vegeto A
    Transplant Proc; 1999; 31(1-2):294-5. PubMed ID: 10083113
    [No Abstract]   [Full Text] [Related]  

  • 19. Cadaveric kidney transplantation: effect of cold ischemia time and HLA match.
    Haberal M; Karakayali H; Moray G; Demirag A; Ozyaylali I; Turan M; Bilgin N
    Transplant Proc; 1999 Dec; 31(8):3336-7. PubMed ID: 10616497
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.